Proliferative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the MIB-1 antibody

Neurosurgery

Volumn 38, Issue 1, 1996, Pages 99-107

  Thapar, Kamal ^a   Kovacs, Kalman ^a   Scheithauer, Bernd W ^b   Stefaneanu, Lucia ^a   Horvath, Eva ^a   Pernicone, Peter J ^c   Murray, David ^a   Laws Jr , Edward R ^d  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b MAYO CLINIC   (United States)

^c FLORIDA HOSPITAL   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Invasiveness; Ki 67; Pituitary adenomas; Pituitary carcinomas; Proliferation markers

Indexed keywords

MONOCLONAL ANTIBODY KI 67; TUMOR MARKER;

ADULT; ARTICLE; AUTOANALYSIS; CANCER INVASION; CELL PROLIFERATION; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; CARCINOMA; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PARANEOPLASTIC ENDOCRINE SYNDROMES; PITUITARY GLAND; PITUITARY NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030060379     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199601000-00024     Document Type: Article

References (28)

1. Alvaro V, Levy L, Dubray C, Roche A, Peillon F, Querat B, Joubert D: Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C. J Clin Endocrinol Metab 77:1125-1129, 1993.
2. Anniko M, Tribukait B, Wersall J: DNA ploidy and cell phase in human pituitary tumors. Cancer 53:1708-1713, 1984.
3. Brown DC, Gatter KC: Monoclonal antibody Ki-67: Its use in histopathology. Histopathology 17:489-503, 1990.
4. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357-363, 1992.
5. Fitzgibbons PL, Appley AJ, Turner RR, Bishop PC, Parker JW, Breeze RE, Weiss MH, Apuzzo MLJ: Flow cytometric analysis of pituitary tumors: Correlation of nuclear antigen p105 and DNA content with clinical behavior. Cancer 62:1556-1560, 1988.
6. Gerdes J: Ki-67 and other proliferation markers useful for immuno-histological diagnostic and prognostic evaluations in human malignancies, in Osborn M (ed): Cancer Biology. London, Saunders Scientific Publications, 1990, pp 99-206.
7. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710-1715, 1984.
8. Hall PA, Woods AL: Immunohistochemical markers of cellular proliferation: Achievements, problems, and prospects. Cell Tissue Kinet 23:505-522, 1990.
9. Hopf NJ, Bremm J, Bohl J, Perneczky A: Image analysis of proliferating cells in tumors of the human nervous system: An immunohistological study with the monoclonal antibody Ki-67. Neurosurgery 35:917-923, 1994.
10. Hsu DW, Hakim F, Biller BMK, De La Monte S, Zervas NT, Klibanski A, Hedley-Whyte ET: Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 78:753-761, 1993.
11. Hsu SM, Raine L, Fanger H: The use of antiavidin antibody and avidin-biotin peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 75:816-821, 1981.
12. Knosp E, Kitz K, Perneczky A: Proliferation activity in pituitary adenomas: Measurement by monoclonal antibody Ki-67. Neurosurgery 25:927-930, 1989.
13. Kovacs K, Horvath E: Tumors of the pituitary gland, in Atlas of Tumor Pathology. Washington, DC, Armed Forces Institute of Pathology, 1986, fascicle 21, series 2, pp 1-269.
14. Landolt A, Shibata T, Kleihues P: Growth rate of human pituitary adenomas. J Neurosurg 67:803-806, 1987.
15. Laws ER Jr, Scheithauer BW, Carpenter S, Randall RV, Abboud CF: The pathogenesis of acromegaly: Clinical and immunocytochemical analysis in 75 patients. J Neurosurg 63:35-38, 1985.
16. Martins AN, Hayes GJ, Kempe LG: Invasive pituitary adenomas. J Neurosurg 22:268-276, 1965.
17. Mork SJ, Laerum OD: Modal DNA content of human intracranial neoplasms studied by flow cytometry. J Neurosurg 53:198-204, 1980.
18. Nagashima T, Murovic JA, Hoshino T, Wilson CB, DeArmond SJ: The proliferative potential of human pituitary tumors in situ. J Neurosurg 64:588-593, 1986.
19. Pernicone PJ, Scheithauer BW: Invasive pituitary adenomas and pituitary carcinomas, in Lloyd RV (ed): Surgical Pathology of the Pituitary Gland. Philadelphia, W.B. Saunders, Co., 1993, pp 121-136.
20. Pernicone PJ, Scheithauer BW, Kovacs K, Sebo T: Pituitary carcinoma: A clinicopathologic and proliferative cell nuclear antigen study of nine cases. Endocr Pathol 3[Suppl 1]:S36, 1992 (abstr).
21. Randall RV, Laws ER Jr, Abboud CF, Ebersold MJ, Kao PC, Scheithauer BW: Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas: Results in 100 patients. Mayo Clin Proc 58:108-121, 1983.
22. Riegelman RK, Hirsch RP: Studying a Study and Testing a Test. Boston, Little, Brown and Company, 1989, pp 151-165.
23. Scheithauer BW, Kovacs KT, Laws ER Jr, Randall RV: Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65:733-744, 1986.
24. Selman WR, Laws ER Jr, Scheithauer BW, Carpenter SM: The occurrence of dural invasion in pituitary adenomas. J Neurosurg 64:402-407, 1986.
25. Stefaneanu L, Horvath E, Kovacs K: Argyrophil organizer region proteins (AgNORs) in adenohypophysial cells and adenomas of the human pituitary. Mod Pathol 2:192-199, 1989.
26. Taylor CR, Shan-Rong S, Chaiwun B, Young L, Imam SA, Cote RJ: Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: Androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques. Hum Pathol 25:263-270, 1994.
27. Wilson CB: A decade of pituitary microsurgery: The Herbert Olivecrona Lecture. J Neurosurg 61:814-833, 1984.
28. Wintzer HO, Zipfel I, Schulte-Monting J, Hellerich U, von Kleist S: Ki-67 immunostaining in human breast tumors and its relationship to prognosis. Cancer 67:421-428, 1990.